From February 7, 2022 to March 31, 2022, the company has repurchased 750,342 shares, representing 0.05% for CNY 7.44 million. With this, the company has completed the repurchase of 750,342 shares, representing 0.05% for CNY 7.44 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.81 CNY | +0.20% | -2.58% | -4.01% |
25/04 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/03 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.01% | 226.05Cr | |
-2.00% | 9.03TCr | |
-1.18% | 4.01TCr | |
-15.80% | 3.17TCr | |
+62.86% | 2.66TCr | |
-21.86% | 1.44TCr | |
-8.60% | 1.29TCr | |
-15.05% | 1.14TCr | |
-45.69% | 1.13TCr | |
+4.94% | 886.85Cr |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.